Time Minimizing in anticancer drug discovery

Suhud, Farida (2018) Time Minimizing in anticancer drug discovery. In: Pharmnano Ubaya 2018, 23-24 Agustus 2018, Ibis Style Surabaya.

[thumbnail of Rev PPT Time Minimizing in  anticncer drug discovery.pdf]
Rev PPT Time Minimizing in anticncer drug discovery.pdf

Download (1MB) | Preview


Nowadays, there are plenty of anticancer drugs on the market, and yet there is still an issue in its clinical usage. This is not caused by the absence of anticancer activity, more likely caused by the low bioavailability and high toxicity. Therefore, it motivates researchers to continue the research on effective and safe novel anticancer drug. Synthesis and activity test towards the novel drug are time consuming and costly. In the past, it is even impossible to predict bioavailability, anticancer activity, and toxicity. However, along with the development of new software to predict bioavailability, activity, and toxicity, such issues are becoming more manageable. This approach will ensure benefit in terms of efficiency. It can minimize the amount of trial and error during the process of novel drug candidate selection. Following the use of this software, if the prospective drug compound is predicted to have anti-cancer activity with low bioavailability and high toxicity, further synthesis and activity test in laboratory are no longer needed.

Item Type: Conference or Workshop Item (Paper)
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: Faculty of Pharmacy > Department of Pharmacy
Depositing User: Ester Sri W. 196039
Date Deposited: 03 Oct 2018 01:44
Last Modified: 03 Oct 2018 01:44
URI: http://repository.ubaya.ac.id/id/eprint/33556

Actions (login required)

View Item View Item